Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination (Acta Neuropathol, (2016), 131, (281–298), 10.1007/s00401-015-1521-1);Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination

Acta Neuropathologica

Volumn 131, Issue 2, 2016, Pages 281-298

  Syed, Yasir A ^a,c   Zhao, Chao ^a   Mahad, Don ^b   Möbius, Wiebke ^c   Altmann, Friedrich ^d   Foss, Franziska ^e   Sentürk, Aycan ^e   Acker Palmer, Amparo ^e   Lubec, Gert ^f,h   Lilley, Kathryn ^a   Franklin, Robin J M ^a   Nave, Klaus A ^c   Kotter, Mark R N ^a,c,g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Chancellor's Building   (United Kingdom)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^e GOETHE UNIVERSITY   (Germany)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h UNIVERSITY OF VIENNA   (Austria)

Author keywords

EphrinB3; Multiple sclerosis; Oligodendrocytes; Remyelination

Indexed keywords

EPHRIN B3; EPHRIN RECEPTOR A4; IMMUNOGLOBULIN FC FRAGMENT; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE; EPITOPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DISEASE MODEL; FEMALE; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MYELIN SHEATH; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPHRIN-B3; EPITOPES; FEMALE; HUMANS; MACROPHAGES; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; NEURAL STEM CELLS; NEUROGENESIS; OLIGODENDROGLIA; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPHA4;

EID: 84954398248     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-017-1712-z     Document Type: Erratum

References (53)

1. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966–972. doi:10.1038/nm1279
2. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, ffrench-Constant C, Franklin RJM, Altmann F, Lubec G, Kotter MRN (2009) Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132:465–481. doi:10.1093/brain/awn334
3. Baron W, de Vries EJ, de Vries H, Hoekstra D (1999) Protein kinase C prevents oligodendrocyte differentiation: modulation of actin cytoskeleton and cognate polarized membrane traffic. J Neurobiol 41:385–398
4. Benson MD, Romero MI, Lush ME, Lu QR, Henkemeyer M, Parada LF (2005) Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci USA 102:10694–10699. doi:10.1073/pnas.0504021102
5. Bieber AJ, Kerr S, Rodriguez M (2003) Efficient central nervous system remyelination requires T cells. Ann Neurol 53:680–684
6. Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271–278
7. Blakemore WF (1974) Pattern of remyelination in the CNS. Nature 249:577–578
8. Bourgin C, Murai KK, Richter M, Pasquale EB (2007) The EphA4 receptor regulates dendritic spine remodeling by affecting beta1-integrin signaling pathways. J Cell Biol 178:1295–1307. doi:10.1083/jcb.200610139
9. Bunge MB, Bunge RP, Pappas GD (1962) Electron microscopic demonstration of connections between glia and myelin sheaths in the developing mammalian central nervous system. J Cell Biol 12:448–453
10. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404–6412
11. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165–173. doi:10.1056/NEJMoa010994
12. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C (2000) Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 97:7585–7590
13. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C (2002) Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125:1972–1979
14. Chumley MJ, Catchpole T, Silvany RE, Kernie SG, Henkemeyer M (2007) EphB receptors regulate stem/progenitor cell proliferation, migration, and polarity during hippocampal neurogenesis. J Neurosci 27:13481–13490. doi:10.1523/JNEUROSCI.4158-07.2007
15. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M (2004) Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271:263–271. doi:10.1016/j.ydbio.2004.03.026
16. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD (1994) Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266:816–819
17. Dodelet VC, Pasquale EB (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19:5614–5619. doi:10.1038/sj.onc.1203856
18. Duffy P, Wang X, Siegel CS, Tu N, Henkemeyer M, Cafferty WB, Strittmatter SM (2012) Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci USA 109:5063–5068. doi:10.1073/pnas.1113953109
19. Fancy SP, Zhao C, Franklin RJM (2004) Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247–254
20. Fancy SPJ, Baranzini SE, Zhao C, Yuk D-I, Irvine K-A, Kaing S, Sanai N, Franklin RJM, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571–1585
21. Forrest AD, Beggs HE, Reichardt LF, Dupree JL, Colello RJ, Fuss B (2009) Focal adhesion kinase (FAK): a regulator of CNS myelination. J Neurosci Res 87:3456–3464. doi:10.1002/jnr.22022
22. Franklin RJM (2002) Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705–714. doi:10.1038/nrn917
23. Franklin RJM, ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839–855. doi:10.1038/nrn2480
24. Franklin RJM, Hinks GL, Woodruff RH, O’Leary MT (2001) What roles do growth factors play in CNS remyelination? Prog Brain Res 132:185–193. doi:10.1016/S0079-6123(01)32075-7
25. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T (2009) Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72:1914–1921. doi:10.1212/WNL.0b013e3181a8260a
26. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451:1076–1081. doi:10.1038/nature06559
27. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115–1121
28. Kotter MRN, Li WW, Zhao C, Franklin RJM (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328–332
29. Kotter MRN, Setzu A, Sim FJ, Van Rooijen N, Franklin RJM (2001) Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35:204–212
30. Kotter MRN, Stadelmann C, Hartung HP (2011) Enhancing remyelination in disease–can we wrap it up? Brain 134:1882–1900. doi:10.1093/brain/awr014
31. Kotter MRN, Zhao C, van Rooijen N, Franklin RJM (2005) Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18:166–175. doi:10.1016/j.nbd.2004.09.019
32. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749–1758. doi:10.1093/brain/awn096
33. Kullander K, Croll SD, Zimmer M, Pan L, McClain J, Hughes V, Zabski S, DeChiara TM, Klein R, Yancopoulos GD, Gale NW (2001) Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev 15:877–888. doi:10.1101/gad.868901
34. Lau LW, Keough MB, Haylock-Jacobs S, Cua R, Doring A, Sloka S, Stirling DP, Rivest S, Yong VW (2012) Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann Neurol 72:419–432. doi:10.1002/ana.23599
35. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122(Pt 12):2279–2295
36. Minagar A, Alexander JS (2003) Blood-brain barrier disruption in multiple sclerosis. Mult Scler 9:540–549
37. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM, ffrench-Constant C (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211–1218. doi:10.1038/nn.3469
38. Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468:244–252. doi:10.1038/nature09614
39. Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford ND, Roth GP, Pasquale EB (2008) Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J Biol Chem 283:29461–29472. doi:10.1074/jbc.M804103200
40. Prestoz L, Chatzopoulou E, Lemkine G, Spassky N, Lebras B, Kagawa T, Ikenaka K, Zalc B, Thomas JL (2004) Control of axonophilic migration of oligodendrocyte precursor cells by Eph-ephrin interaction. Neuron Glia Biol 1:73–83. doi:10.1017/S1740925X04000109
41. Robinson S, Miller RH (1999) Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 216:359–368
42. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJM (2012) Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10:96–103. doi:10.1016/j.stem.2011.11.019
43. Senturk A, Pfennig S, Weiss A, Burk K, Acker-Palmer A (2011) Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. Nature 472:356–360. doi:10.1038/nature09874
44. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, ffrench-Constant C, Franklin RJM (2006) Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54:297–303
45. Sherman DL, Brophy PJ (2005) Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683–690. doi:10.1038/nrn1743
46. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T (2010) Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 107:11555–11560. doi:10.1073/pnas.1006496107
47. Syed YA, Baer A, Hofer MP, Gonzalez GA, Rundle J, Myrta S, Huang JK, Zhao C, Rossner MJ, Trotter MW, Lubec G, Franklin RJM, Kotter MRN (2013) Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. EMBO Mol Med 5:1918–1934. doi:10.1002/emmm.201303123
48. Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MRN (2008) Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg Focus 24:E5. doi:10.3171/FOC/2008/24/3-4/E4
49. Syed YA, Hand E, Mobius W, Zhao C, Hofer M, Nave KA, Kotter MRN (2011) Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 31:3719–3728. doi:10.1523/JNEUROSCI.4930-10.2011
50. Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RL (2006) Immunohistochemical staining of post-mortem adult human brain sections. Nat Prot 1:2719–2732. doi:10.1038/nprot.2006.354
51. Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C (2007) Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain. doi:10.1093/brain/awm202
52. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601–609
53. Woodruff RH, Franklin RJM (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25:216–228